Home / Health / Expert Warns: Overuse of Weight Loss Meds Sparks Alarms
Expert Warns: Overuse of Weight Loss Meds Sparks Alarms
17 Jun
Summary
- GLP-1 medications, once for diabetes, are now widely used for weight loss.
- Experts warn of severe health risks and misuse of these potent drugs.
- These drugs are intended for chronic health conditions, not cosmetic shortcuts.
Medications originally intended for type 2 diabetes management, such as semaglutide and Tirzepatide (GLP-1 receptor agonists), are now seeing a surge in global use for weight management. India, with its significant metabolic disorder rates, has become a prime market for these drugs, drawing curiosity amid rising obesity awareness.
However, medical experts, including Dr. Anshuman Kaushal, are sounding alarms over the prevalent misuse of these potent medications. They caution that the drive for quick cosmetic transformations on social media is overshadowing the drugs' intended purpose as aggressive medical interventions for severe chronic health complications.
Dr. Kaushal highlights that GLP-1 medications yield remarkable outcomes when used under strict clinical supervision and combined with lifestyle changes. They are specifically recommended for individuals battling obesity, diabetes, hypertension, fatty liver disease, or sleep apnea syndrome, not for superficial aesthetic goals.
